Biomarkers in lung cancer: from early detection to novel therapeutics and decision making.
Publication
, Journal Article
Scott, A; Salgia, R
Published in: Biomark Med
December 1, 2008
Lung cancer remains a significant cause of mortality worldwide. While advances in therapy continue to be made, the overall prognosis for patients diagnosed with lung cancer remains poor. Historically, markers such as age, performance status and disease stage have been used to risk-stratify patients and guide therapeutic decisions. These parameters provide some useful information, but more sensitive markers are clearly needed. Molecular and genetic studies have identified several such markers, which appear to play critical roles in carcinogenesis and affect patient outcomes. This article reviews a number of biomarkers that have been identified in lung cancer, and their prognostic and predictive roles.
Duke Scholars
Published In
Biomark Med
DOI
EISSN
1752-0371
Publication Date
December 1, 2008
Volume
2
Issue
6
Start / End Page
577 / 586
Location
England
Related Subject Headings
- Oncology & Carcinogenesis
- 3404 Medicinal and biomolecular chemistry
- 3205 Medical biochemistry and metabolomics
- 3202 Clinical sciences
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics
- 0304 Medicinal and Biomolecular Chemistry
Citation
APA
Chicago
ICMJE
MLA
NLM
Scott, A., & Salgia, R. (2008). Biomarkers in lung cancer: from early detection to novel therapeutics and decision making. Biomark Med, 2(6), 577–586. https://doi.org/10.2217/17520363.2.6.577
Scott, April, and Ravi Salgia. “Biomarkers in lung cancer: from early detection to novel therapeutics and decision making.” Biomark Med 2, no. 6 (December 1, 2008): 577–86. https://doi.org/10.2217/17520363.2.6.577.
Scott A, Salgia R. Biomarkers in lung cancer: from early detection to novel therapeutics and decision making. Biomark Med. 2008 Dec 1;2(6):577–86.
Scott, April, and Ravi Salgia. “Biomarkers in lung cancer: from early detection to novel therapeutics and decision making.” Biomark Med, vol. 2, no. 6, Dec. 2008, pp. 577–86. Pubmed, doi:10.2217/17520363.2.6.577.
Scott A, Salgia R. Biomarkers in lung cancer: from early detection to novel therapeutics and decision making. Biomark Med. 2008 Dec 1;2(6):577–586.
Published In
Biomark Med
DOI
EISSN
1752-0371
Publication Date
December 1, 2008
Volume
2
Issue
6
Start / End Page
577 / 586
Location
England
Related Subject Headings
- Oncology & Carcinogenesis
- 3404 Medicinal and biomolecular chemistry
- 3205 Medical biochemistry and metabolomics
- 3202 Clinical sciences
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics
- 0304 Medicinal and Biomolecular Chemistry